|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
| City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
||||||||
| TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 7/20/2017 5:32:39 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 1628 American Healthcare Act/Better Care Reconciliation Act - Protecting the Affordable Care Act coverage gains from being lost.
HR 5926 & S 3068 - HHS FY 2017 appropriations priorities: AHRQ, Health Resources & Services Admin, Title VII, NHSC: Federal spending priorities to support workforce, research.
No Bill No.- Teaching Health Centers GME program: Support continued funding for THC program; Continued funding for the THCGME program, Dear Colleague letter.
No Bill No. - FY2018 appropriations for CDC: AAFP federal spending priorities on prevention and public health.
No Bill No. - Appropriations for AHRQ in FY 2018: AAFP federal spending priorities for primary care research.
No Bill No. - FY2018 appropriations for HRSA Titles VII & X, NHSC: AAFP Federal spending priorities for primary care training, family planning, student debt relief & healthcare workforce.
No Bill No. - Healthcare workforce: Increasing the Family Physician workforce
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agency for Healthcare Research & Quality (AHRQ), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
No Bill No. - Teaching Health Center GME: help educate members about the need to extend the program.
No Bill No. - Teaching Health Center GME Reauthorization Act: TCH Reauthorization.
No Bill No. - Appropriations for AHRQ in FY 2018: AAFP federal spending priorities for primary care research.
No Bill No. Congressional Primary Care Caucus: Urge Members to join the caucus and support primary care to achieve the triple aim in healthcare.
No Bill No. - Family Medicine Advocacy Summit: Set up office visits with legislators; draft talking points and issue papers.
No Bill No. - Teaching Health Center GME: support continued funding for THC program.
No Bill No. - FY2018 appropriations for HRSA Titles VII & X, NHSC: AAFP Federal spending priorities for primary care training, family planning, student debt relief & healthcare workforce.
No Bill No. - Healthcare workforce: Increasing the family physician workforce.
No Bill No.- Teaching Health Centers GME program: Support continued funding for THC program; Continued funding for the THCGME program, Dear Colleague letter.
FY 2017 appropriations priorities: AHRQ, Health Resources & Services Admin, Title VII, NHSC: Federal spending priorities to support workforce, research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1215 Protecting Access to Care Act of 2017: Urge reform of medical liability law
HR 1215 the Protecting Access to Care Act of 2017: Urge defeat of this legislation
HR 1628 - American Health Care Act (Repeal and Replace Obamacare): educate members and staff on AAFP's positions on Health Care for all; advocate for changes to the AHCA and ultimately lobby against the bill; Protecting ACA coverage gains from being lost.
No Bill No. - Primary Care Insurance Benefit: educate members on AAFP's policy for a primary-care insurance benefit for HDHP's.
No Bill No. - Direct Primary Care: Advocate for introduction and co-sponsorship of a bill to allow more patient access to the DPC model.
No Bill No. - Nominations to HIT advisory committee: Getting FP's appointed to HIT advisory committee.
No Bill No - Correspondence to Trump on access to care.
No Bill No - Correspondence to PTAC on APC-APM: Primary care payment model
No Bill No - Correspondence to AHRQ with USPSTF nominations: Getting FPs appointed to a public health advisory committee.
No Bill No - correspondence to ASPE on nominations: appointed FPs to HHS advisory committee.
No Bill No. - Teaching Health Center GME Reauthorization Act: TCH Reauthorization; continued funding for THCGME program, Dear Colleague letter.
No Bill No. - Adult Vaccines; Medicare, ACA Coverage, Prevention Fund
No Bill No. - Family Medicine Advocacy Summitt: Setting up meetings on target issues.
No Bill No. - FY 2017 appropriations AHRQ, Health Resources & Services Admin, Title VII, NHSC: Federal spending priorities to support workforce, research.
No Bill No. Congressional Primary Care Caucus: Urge Members to join the caucus and support primary care to achieve the triple aim in healthcare.
No Bill No. - Family Medicine Advocacy Summit: Set up office visits with legislators; draft talking points and issue papers; Speaker & Meeting scheduling, Health care coverage, THCGME, Primary Care Caucus.
No Bill No. - FY2018 appropriations for CDC: AAFP federal spending priorities on prevention and public health.
No Bill No. - Opioid Abuse: Support increased investment in treatment, Medicaid expansion, Prescription Drug Monitoring Program, Naloxone
No Bill No: FY2018 appropriations for AHRQ: AAFP federal spending priorities for primary care research.
No Bill No. - FY2018 appropriations for HRSA Titles VII & X, NHSC: AAFP Federal spending priorities for primary care training, family planning, student debt relief & healthcare workforce.
No Bill No. - Healthcare workforce: Increasing the family physician workforce.
No Bill No. - House Caucus on Maternity Care: Health mothers and babies.
No Bill No. - House primary Care Caucus: Promoting Primary Care.
No Bill No. FY17 Ag appropriations bill FDA & Labor-H cuts to CDC Office on Smoking and Health.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Sonya |
Clay |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1215 Protecting Access to Care Act of 2017: Urge passage of this legislation.
HR 1628 - American Health Care Act: Medicaid, Prevention, Reproductive Health, consumer protections; Urge defeat of legislation to repeal and replace.; Protecting ACA coverage gains from being lost.
No Bill No. - Nominations to HIT advisory committee: Getting FPS appointed to HIT advisory committee.
No Bill No. - Correspondence to PTAC on APC-APM: Primary care payment model.
No Bill No. - Correspondence to CMS on how to improve MACRA: Improving how CMS implements MACRA for primary care.
No Bill No. - Correspondence to CMS on SSNRI - Medicare beneficiary cards.
No Bill No. - Correspondence to CMS on site neutral payments: outpatient payments being site neutral.
No Bill No. - Correspondence to CMS on 2018 proposed IPPS: How to reduce regluatory burden for FPs
No Bill No.- Congressional Primary Care Caucus: Urge members to join the Caucus and support Primary Care to achieve the triple aim in healthcare.
No Bill No. - Family Medicine Advocacy Summit: Set up office visits with legislators; draft talking points and issue papers; Speaker & Meeting scheduling, Health care coverage, THCGME, Primary Care Caucus.
No Bill No. - Teaching Health Centers GME program: Support continued funding for THC program.
No Bill No. - FY2018 appropriations for CDC: AAFP federal spending priorities on prevention and public health.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Sonya |
Clay |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
No Bill No. - House caucus on Maternity Care: Healthy mothers and babies
No Bill No. - Opioid Abuse: Support increased investment in treatment, Medicaid expansion, Prescription Drug Monitoring Program, Naloxone
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR 1628 - American Health Care Act: Medicaid, Prevention, Reproductive Health, consumer protections
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 1215 Protecting Access to Care Act of 2017: Urge reform of medical liability law
HR 1628 - American Health Care Act of 2017/Better Care Reconciliation: urge defeat of HR 1628; educate members and staff on AAFP's positions on Health Care for all; advocate for changes to the AHCA and ultimately lobby against the bill; Protecting ACA coverage gains from being lost.
No Bill No - Direct Primary Care: advocate for introduction and co-sponsorship of a bill to allow more patients access to the DPC model.
No Bill No. - Family Medicine Advocacy Summit: Set up office visits with legislators; draft talking points and issue papers; Speaker & Meeting scheduling, Health care coverage, THCGME, Primary Care Caucus.
No Bill No: FY2018 appropriations for CDC: AAFP federal spending priorities on prevention and public health.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
|
|
Andrew |
Adair |
|
|
|
Mark |
Cribben |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
HR 1628 - American Health Care Act: Medicaid, Prevention, Reproductive Health, consumer protections,
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
No Bill No. - Correspondence to FDA on e-cigarette batteries: Exploding batteries.
No Bill No. - Correspondence to HHS on FDA deeming: FDA jurisdiction over nicotine delivery devices.
No Bill No. - FY17 Ag Appropriations bill FDA & Labor-H cuts to CDC Office on Smoking and Health: Public Tobacco prevention.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
|
|
Robert |
Bennett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
HR 1215 Protecting Access to Care Act - Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
No Bill No. Correspond to VA nominating FPs: Getting FPs appointed to VA advisory committee
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
No Bill No. - Correspond with FDA on food labeling: Getting FDA to require food menu labeling laws.
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |